Dissemin is shutting down on January 1st, 2025

Published in

National Academy of Sciences, Proceedings of the National Academy of Sciences, 28(114), 2017

DOI: 10.1073/pnas.1707054114

Links

Tools

Export citation

Search in Google Scholar

Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Significance Quantitative mass spectrometric profiling of the extracellular matrix composition of normal lung, fibrotic lung, primary lung tumors, and lung metastases to the lymph nodes uncovered specific signatures distinguishing these tissues. CRISPR/Cas9-mediated gene activation of one of the identified factors, Tenascin-C (Tnc), showed that this protein plays a role in mediating lung adenocarcinoma metastasis. Tnc expression is repressed, directly or indirectly, by the transcription factor Nkx2-1. Bioinformatic analysis shows that expression of three matrisome factors ( TNC , S100A10 , and S100A11 ) can predict survival in patients with lung adenocarcinoma. These factors could serve as disease markers that could be exploited for better diagnosis of lung cancer, and their future study could be used to inform the design of more potent treatments for patients.